New ambulatory care centers open in Wailuku and Upcountry, Maui

Hawaiʻi Specialty Pharmacy (HSP) today announced the opening of two new ambulatory infusion centers on Maui—in Wailuku and Upcountry.

• HSP Upcountry, located at 40 Kupaoa St., No. B202 in Makawao, is already operational, offering comprehensive services to meet patients’ needs.
• HSP Wailuku, located at 1885 Main St., No. 207 in Wailuku, is currently open with limited services, with plans for full-scale operations later this year.

“HSP’s new infusion centers are staffed five days per week with highly trained nurses, providing patients with a safe, secure environment in which to receive their infused therapies and other treatments,” according to a news release announcement.

“Empowering our community with comprehensive healthcare solutions has always been at the heart of Hawaiʻi Specialty Pharmacy’s mission,” said George Kridner, PharmD, CEO of Hawaiʻi Specialty Pharmacy. “These new infusion centers will help extend our offerings to even more local patients and families, further cementing our role as a valuable, trusted part of the community.”

Since its inception in 2018, Hawaiʻi Specialty Pharmacy provides specialty drug therapies and nursing services, including home infusion support, to the community to help ensure patients receive the treatments they need when and where they need them.

To commemorate the opening of the new infusion centers, HSP is extending an invitation to local media, healthcare providers, and community members to attend a welcome reception at the HSP Upcountry location on Thursday, May 16, from 5:30 to 7:30 p.m.

The reception will include opening remarks from CEO George Kridner and Dr. Cecilia Choi, an oncologist at Maui Care Physicians, along with a tour of the facility and cocktails and light refreshments. There will also be a private, traditional Hawaiian blessing of the grounds for the HSP team and local physicians. The reception serves as an opportunity for the new infusion center staff and local patients and community members to get to know one another and for HSP to express its gratitude to the community.

“Patients who are undergoing chemotherapy or other infusions or specialty treatments for their conditions are often dealing with a lot of physical and emotional challenges relating to their illness,” said Dr. Choi. “Logistical challenges should not be added to those burdens. I’m so glad to have a welcoming, convenient option to offer my patients. Maui is excited to welcome these new infusion centers and their staff into the heart of our community.”

Specialty pharmacies and ambulatory infusion centers support patients requiring specialized treatments, including chemotherapy, antibiotic infusions, and more. With a focus on diseases including cancer, rheumatoid arthritis, multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, ulcerative colitis and others, these centers continue to be instrumental in the shift of care from hospitals to home.

The global Ambulatory Infusion Center market size was valued at $75,440 million in 2023 and is forecast to reach $133,690 millionby 2030, with a compound annual growth rate of 8.5% during the review period.